WBC
CLX icon

West Branch Capital’s Clorox CLX Stock Holding History

West Branch Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21
Closed -$2.54K – 424
2025
Q3 		$2.54K Buy
21
+1
+5% +$124 ﹤0.01% 356
2025
Q2 		$2.44K Sell
20
-232
-92% -$31K ﹤0.01% 369
2025
Q1 		$37.2K Sell
252
-502
-67% -$76.7K 0.01% 174
2024
Q4 		$122K Buy
754
+6
+0.8% +$982 0.04% 103
2024
Q3 		$122K Buy
748
+6
+0.8% +$889 0.04% 103
2024
Q2 		$101K Sell
742
-98
-12% -$13.6K 0.04% 121
2024
Q1 		$129K Sell
840
-63
-7% -$9.4K 0.05% 104
2023
Q4 		$129K Buy
903
+77
+9% +$10.3K 0.06% 95
2023
Q3 		$108K Buy
826
+6
+0.7% +$912 0.06% 105
2023
Q2 		$130K Buy
820
+6
+0.7% +$968 0.07% 100
2023
Q1 		$129K Buy
814
+6
+0.7% +$900 0.07% 99
2022
Q4 		$113K Buy
808
+7
+0.9% +$994 0.07% 108
2022
Q3 		$103K Buy
801
+6
+0.8% +$866 0.06% 110
2022
Q2 		$112K Buy
795
+6
+0.8% +$857 0.06% 110
2022
Q1 		$110K Sell
789
-158
-17% -$24.2K 0.05% 120
2021
Q4 		$165K Sell
947
-140
-13% -$23.3K 0.07% 102
2021
Q3 		$180K Sell
1,087
-22
-2% -$3.79K 0.09% 89
2021
Q2 		$199K Sell
1,109
-26
-2% -$4.75K 0.1% 88
2021
Q1 		$219K Buy
1,135
+46
+4% +$8.86K 0.13% 84
2020
Q4 		$220K Sell
1,089
-81
-7% -$16.8K 0.13% 83
2020
Q3 		$246K Buy
1,170
+5
+0.4% +$1.11K 0.16% 74
2020
Q2 		$256K Buy
1,165
+5
+0.4% +$999 0.18% 68
2020
Q1 		$201K Buy
+1,160
New +$192K 0.19% 73

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

West Branch Capital's CLX Position: Q4 2025 in Review

West Branch Capital sold out of Clorox (CLX) in Q4 2025, closing a stake of 21 shares — an estimated $2.54K sold.

West Branch Capital first reported a position in CLX in Q1 2020 and held it in 23 quarters. The position peaked at $256K in Q2 2020. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • West Branch Capital reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • West Branch Capital sold 21 Clorox shares in Q4 2025, an estimated $2.54K.
  • West Branch Capital first reported a position in Clorox in Q1 2020 and held it in 23 quarters.
  • West Branch Capital's Clorox position peaked at $256K in Q2 2020.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on West Branch Capital's 13F filing for Q4 2025, filed 16 Jan 2026.